Does tirzepatide have side effects — and how serious are they?

The biggest myth: side effects mean the medicine isn't working

The most common misconception our prescribers hear is that nausea or stomach discomfort signals a problem with the treatment itself. In reality, the GI effects seen with tirzepatide are a predictable consequence of how the medicine works. Tirzepatide activates both GIP and GLP-1 receptors, slowing how quickly food leaves the stomach and increasing feelings of fullness. That gastric-slowing effect is central to its action on appetite, and it is also the reason the digestive system needs time to adjust.

In SURMOUNT-1, the pivotal phase-3 trial involving around 2,500 adults, gastrointestinal events were the most frequently reported adverse effects across all doses. Nausea was the most common, followed by diarrhoea, vomiting, constipation, and indigestion. Crucially, the majority of these were mild to moderate in severity, and most resolved within days to a couple of weeks as the body settled. The graduated dosing schedule (starting at 2.5 mg, with increases in 4-week steps) exists precisely to let the gut adapt gradually rather than being hit hard from the start. You can read a detailed breakdown of what side effects tirzepatide causes and how they compare across doses.

Other commonly reported effects include fatigue, headache, dizziness, and reactions at the injection site such as redness or mild bruising. If you want a fuller picture before you begin, our guide to side effects from tirzepatide walks through each one and explains why it tends to occur. Rotating injection sites between the abdomen, thigh, and upper arm reduces localised skin irritation over time, a simple habit that takes under a minute to build into your routine.

Side effects that need medical attention, and one that needs it urgently

Not every side effect is something to wait out at home. The MHRA's Drug Safety Update of 29 January 2026 highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 medicines including tirzepatide. The warning sign is severe, persistent abdominal pain that may spread to the back, sometimes accompanied by vomiting. If this happens, stop eating and drinking and seek urgent medical care, do not wait to see if it passes.

Other symptoms that warrant prompt attention rather than a wait-and-see approach include: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heartbeat); symptoms of gallbladder problems such as sharp pain in the upper right abdomen, jaundice or pale stools; and signs of dehydration if vomiting or diarrhoea has been prolonged, particularly reduced urination, dizziness when standing, or confusion. Anyone using tirzepatide who is also managing diabetes should be alert to low blood sugar, especially if they are taking other glucose-lowering medicines alongside it.

Our Mounjaro side effects page covers these warning signs in more detail, including what to tell a doctor when you call.

Mood, mental health and longer-term questions

One area that comes up regularly is the question of mood changes on tirzepatide. Some people report feeling low, anxious, or emotionally flat, particularly during periods of rapid weight change or when GI discomfort is affecting sleep and daily life. The connection between tirzepatide and mood is something regulators continue to monitor closely, and it is not something to dismiss or push through alone.

If you notice a sustained change in how you feel mentally (low mood, withdrawal from things you usually enjoy, or any thoughts of self-harm) contact your prescriber or GP promptly. This is not a reason to avoid treatment; it is a reason to have the conversation so your care can be adjusted if needed.

Questions also arise about what side effects look like over a longer course of treatment. The evidence on long-term Mounjaro side effects is still building as real-world datasets accumulate, and your prescriber is the right person to discuss any concerns that persist beyond the initial adjustment period. If you are researching before starting, our page covering what side effects Mounjaro has gives a thorough overview that many people find useful at that stage. The NHS tirzepatide page also lists side effects clearly and is a reliable first reference if you want to check a symptom quickly.

Reporting side effects and your role in post-market safety

Tirzepatide's Black Triangle status means the MHRA is actively collecting safety data from real-world use, and patients are part of that system. If you experience a side effect you did not expect, or one that feels more severe than the leaflet describes, you can report it directly through the Yellow Card scheme. You do not need a GP or pharmacist to submit a report on your behalf; the online form takes a few minutes.

The same Yellow Card portal is where you can flag a suspected counterfeit or a seller offering these medicines without a proper prescription, something the MHRA takes seriously given the scale of fake pen seizures in recent years.

At nume, side effects are not a topic saved for after you've started. Our prescribers discuss what you're likely to experience, what to watch for, and how to reach us if something doesn't feel right, before a prescription is issued. If you'd like to talk through your personal picture, start a free consultation and a prescriber will review your case the same day.